Abstract
The purpose of this study was to develop and optimize formulations of mucoadhesive bilayered buccal patches of sumatriptan succinate using chitosan as the base matrix. The patches were prepared by the solvent casting method. Gelatin and polyvinyl pyrrolidone (PVP) K30 were incorporated into the patches, to improve the film properties of the patches. The patches were found to be smooth in appearance, uniform in thickness, weight, and drug content; showed good mucoadhesive strength; and good folding endurance. A 32 full factorial design was employed to study the effect of independent variables viz. levels of chitosan and PVP K30, which significantly influenced characteristics like swelling index, in-vitro mucoadhesive strength, in vitro drug release, and in-vitro residence time. Different penetration enhancers were tried to improve the permeation of sumatriptan succinate through buccal mucosa. Formulation containing 3% dimethyl sulfoxide showed good permeation of sumatriptan succinate through mucosa. Histopathological studies revealed no buccal mucosal damage. It can be concluded that buccal route can be one of the alternatives available for administration of sumatriptan succinate.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Medline Plus A. service of the U.S National Library of Medicine and the National Institutes of Health. Available at: http://medlineplus.gov (2008).
K. L. Dechant, and S. P. Clissold. Sumatriptan. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the acute treatment of migraine and cluster headache. Drugs. 43:776–798 (1992).
R. Ryan, A. Elkind, C. C. Baker, W. Mullican, S. DeBussey, and M. Asgharnejad. Sumatriptan nasal spray for the acute treatment of migraine: results of two clinical studies. Neurology. 49:1225–1230 (1997).
A. H. Shojaei. Buccal mucosa as a route for systemic drug delivery: A Review. J Pharm Pharmaceut. Sci. 1:15–30 (1998).
A. J. Hoogstraate, and P. W. Wertz. Drug delivery via the buccal mucosa. PSTT. 17:309–316 (1998).
J. H. Guo, and K. M. Cooklok. The effects of backing materials and multilayered systems on the characteristics of mucoadhesive buccal patches. J. Pharm Pharmacol. 48:255 (1996).
N. A. Nafee, F. A. Ismail, N. A. Boraie, and L. M. Mortada. Mucoadhesive buccal patches of miconazole nitrate: in vitro/in vivo performance and effect of ageing. Int. J. Pharm. 264:1–14 (2003).
C. R. Lopez, A. Portero, J. L. Vila-Jato, and M. J. Alonso. Design and evaluation of chitosan/ethyl cellulose mucoadhesive bilayered devices for buccal drug delivery. J. Control. Release. 55:143–152 (1998).
V. M. Patel, B. G. Prajapati, and M. M. Patel. Effect of hydrophilic polymers on buccoadhesive Eudragit patches of propranolol hydrochloride using factorial design. AAPS PharmSciTech. 82:Article 45 (2007).
S. Bolton, and C. Bon. Pharmaceutical Statistics, 4th ed., Marcel and Dekker, New York, p. 2005.
A. N. Noha. Design and characterization of mucoadhesive buccal patches containing cetylpyridinium chloride. Acta Pharm. 53:199–212 (2003).
L. Perioli, V. Ambrogi, F. Angelici, M. Ricci, S. Giovagnoli, M. Capuccell, and C. Rossi. Development of mucoadhesive patches for buccal administration of ibuprofen. J. Control. Release. 99:73–82 (2004).
C. F. Wong, K. H. Yuen, and K. K. Peh. Formulation and evaluation of controlled release Eudragit buccal patches. Int J Pharm. 178:11–22 (1999).
A. D. Woolfson, D. F. McCafferty, P. A. McCarron, and J. H. Price. A mucoadhesive patch cervical drug delivery system for the administration of 5-fluorouracil to cervical tissue. J. Control. Release. 35:49–58 (1995).
N. A. Nafee, and F. A. Ismail. Mucoadhesive drug delivery system, formulation and in-vitro evaluation of mucoadhesive tablets containing water soluble drugs. Drug Dev Ind Pharm. 30:9995–1004 (2004).
J. K. Lalla, R. A. Gurnaney, and S. Narayan. Permeation of diclofenac through buccal mucosa. Indian J. Pharm. Sci. 64(4):373–377 (2002).
R. J. Majithiya, P. K. Ghosh, M. L. Umrethia, and R. S. R. Murthy. Thermoreversible mucoadhesive gel for nasal delivery of sumatriptan. AAPS PharmSciTech. 7(3):Article 6 (2006).
K. P. Kok, and F. W. Choy. Polymeric films as vehicle for buccal delivery: swelling, mechanical, and mucoadhesive properties. J. Pharm Pharmaceut Sci. 2(2):53–61 (1999).
M. Bogataj, T. Vovk, M. Kerec, A. Dimnik, I. Grabner, and A. Mrhar. The correlation between zeta potential and mucoadhesion strength on pig vesical mucosa. Biol. Pharm. Bull. 26(5):743–746 (2003).
R. Bodmeier, and O. Paeratakul. Evaluation of drug-containing polymer films prepared from aqueous latexes. Pharm Res. 6:725–730 (1989).
S. Senel, and A. A. Hıncal. Drug permeation enhancement via buccal route: possibilities and limitations. J. Control. Release. 72:133–144 (2001).
J. Hao, and W. S. H. Paul. Buccal delivery systems. Drug Development and Industrial Pharmacy. 29(8):821–832 (2003).
W. A. Ritschel, G. B. Rischel, B. Foruz, and M. Kraeling. Buccal absorption of insulin in the dog. Res. Commun. Chem. Pathol. Pharmacol. 63:53 (1989).
A. Steward, D. L. Bayley, and C. Howes. The effect of enhancers on the buccal absorption of hybrid (BDBB) α-interferon. Int. J. Pharm. 104:145 (1994).
B. J. Aungst, and N. J. Rogers. Comparison of the effects of various transmucosal absorption of promoters on buccal insulin delivery. Int. J. Pharm. 53:227 (1989).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Shidhaye, S.S., Saindane, N.S., Sutar, S. et al. Mucoadhesive Bilayered Patches for Administration of Sumatriptan Succinate. AAPS PharmSciTech 9, 909–916 (2008). https://doi.org/10.1208/s12249-008-9125-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1208/s12249-008-9125-x